Schizophrenia - Nursing Case Study

Pathophysiology

• Primary mechanism: Schizophrenia is primarily associated with dysregulation of dopamine pathways, particularly hyperactivity in the mesolimbic pathway, leading to positive symptoms such as hallucinations and delusions, and hypoactivity in the mesocortical pathway, contributing to negative symptoms like apathy and cognitive deficits.

• Secondary mechanism: Glutamate dysfunction, especially involving NMDA receptor hypofunction, further disrupts synaptic plasticity and connectivity, exacerbating cognitive impairments and negative symptoms by affecting excitatory-inhibitory balance in the brain.

• Key complication: These neurotransmitter imbalances contribute to altered brain structure and function, such as reduced gray matter volume and impaired neural circuitry, which can lead to progressive cognitive decline and social dysfunction in patients with schizophrenia.

Patient Profile

Demographics:

34-year-old male, software engineer

History:

• Key past medical history: Diagnosed with schizophrenia 6 years ago, history of non-compliance with medication

• Current medications: Risperidone 3 mg daily, Lorazepam 1 mg as needed for anxiety

• Allergies: No known drug allergies

Current Presentation:

• Chief complaint: Hearing voices and feeling paranoid about coworkers

• Key symptoms: Auditory hallucinations, delusions of persecution, social withdrawal, difficulty concentrating

• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm, temperature 98.6°F, respiratory rate 20 breaths per minute

Section 1

Change in Patient Status:

During the current hospitalization, the 34-year-old male patient exhibits a notable change in his status. He has become increasingly agitated and is experiencing heightened paranoia, particularly fixated on the belief that his coworkers are conspiring against him. This escalation in symptoms is accompanied by more frequent and distressing auditory hallucinations, which he describes as multiple voices urging him to act defensively. His concentration has further deteriorated, making it challenging for him to engage in even simple conversations or tasks.

Clinically, his vital signs have shown some concerning trends; blood pressure has increased to 158/100 mmHg and heart rate remains elevated at 115 bpm, suggesting heightened autonomic arousal possibly related to his increased anxiety and agitation. A recent assessment also reveals signs of increased psychomotor agitation, such as pacing and inability to sit still during interviews. Additionally, the patient appears more withdrawn, showing reduced eye contact and reluctance to engage with staff or other patients, indicating a potential worsening of his negative symptoms.

These changes in the patient's status necessitate a reevaluation of his current management plan. The healthcare team needs to consider potential factors contributing to this deterioration, such as medication non-compliance, suboptimal dosing of current medications, or new psychosocial stressors. Clinical reasoning should focus on determining whether an adjustment in antipsychotic therapy or the addition of adjunctive treatments might be warranted to address his exacerbated symptoms. Close monitoring of his vital signs and mental status is essential, and a multidisciplinary approach may be required to address both his psychiatric and physiological needs, setting the stage for potential next steps in his care journey.

Section 2

Initial Assessment Findings:

In light of the patient's escalating symptoms, an initial assessment is conducted to gather a comprehensive understanding of his current condition. Upon physical examination, the patient exhibits noticeable signs of heightened stress, with pronounced muscle tension and frequent fidgeting. His speech is pressured and often tangential, making it difficult to maintain a coherent conversation. Collateral history from his family reveals that he has had difficulty sleeping over the past week, with frequent nocturnal awakenings likely contributing to his irritability and increased paranoia.

Neurological examination reveals no focal deficits, but there is a marked increase in psychomotor agitation. During the mental status examination, he is observed to be hypervigilant, scanning the environment frequently as if expecting a threat. When asked about his auditory hallucinations, the patient mentions that the voices have become more commanding and insistent, instructing him to isolate himself from others. This suggests a potential worsening of his condition, possibly linked to external stressors or internal cognitive overload.

Given these findings, the healthcare team considers a multifaceted approach to his management. The increase in blood pressure and heart rate could be indicative of an underlying anxiety disorder exacerbating his psychotic symptoms, suggesting that an adjunctive anxiolytic might be beneficial. The possibility of medication non-compliance is also explored, considering his reluctance to engage and discuss treatment openly. To address his sleep disturbances, a review of his current medication regimen is prioritized to ensure optimal dosing and consider the addition of a sleep aid. These steps are critical in stabilizing his condition, preventing further deterioration, and setting the stage for a more detailed exploration of potential psychosocial stressors contributing to his current state.

Section 3

New Complications:

Following the initial assessment, the healthcare team initiated a treatment plan that included an anxiolytic and a low-dose sleep aid to address the patient's heightened anxiety and sleep disturbances. However, after a few days, the patient presents with new complications that require immediate attention. During a routine check-in, nursing staff observe that the patient is experiencing tachycardia, with a heart rate consistently above 120 beats per minute. Additionally, his blood pressure has spiked to 160/95 mmHg, suggesting that his anxiety and psychotic symptoms may not be adequately controlled. The patient also reports experiencing increased dizziness and occasional palpitations, which are concerning given his current medication regimen.

A repeat mental status examination reveals that the patient is now exhibiting signs of worsening paranoia and delusional thinking. He believes that the healthcare staff are conspiring against him, leading to increased resistance to taking medications. The auditory hallucinations have become more distressing, with voices now telling him that the medications are poison. These developments indicate that the patient is not responding well to the current treatment plan and that his condition may be deteriorating due to medication non-compliance and the possible side effects of the new medications.

Recognizing the urgency of the situation, the healthcare team decides to conduct a comprehensive review of his treatment regimen, including potential drug interactions and side effects. Laboratory tests are ordered to rule out any physiological causes for the tachycardia and hypertension, such as thyroid dysfunction or electrolyte imbalance. The team also considers the introduction of a long-acting injectable antipsychotic to improve medication adherence, given the patient's reluctance to take oral medications. These steps are crucial in addressing the new complications and stabilizing the patient's mental and physical health, paving the way for further therapeutic interventions.

Section 4

As the healthcare team analyzes the new diagnostic results, several key findings emerge that provide insight into the patient's deteriorating condition. The laboratory tests reveal a slightly elevated thyroid-stimulating hormone (TSH) level, suggesting subclinical hypothyroidism, which could partially account for the patient's tachycardia and hypertension. Electrolyte levels, however, remain within normal limits, ruling out imbalances as a cause for the cardiovascular symptoms. Additionally, the EKG performed shows occasional premature ventricular contractions (PVCs), likely exacerbated by the patient's heightened anxiety and potential side effects of the anxiolytic medication. These findings necessitate a reevaluation of the current pharmacological approach, particularly the anxiolytic, which may be contributing to the cardiovascular side effects.

In response to these diagnostic results, the healthcare team convenes to adjust the patient's treatment plan. They decide to taper and discontinue the current anxiolytic, replacing it with a beta-blocker to address both the anxiety and the cardiovascular symptoms. The introduction of a long-acting injectable antipsychotic is prioritized to enhance medication adherence, given the patient's resistance to oral medications and the ongoing paranoia. The team also initiates a thyroid panel follow-up to closely monitor thyroid function, with the potential consideration of thyroid hormone replacement therapy if clinically indicated. Nursing staff are tasked with implementing a structured therapeutic milieu to help reduce anxiety triggers and incorporate cognitive-behavioral strategies to address the patient's paranoia and delusional thinking.

As these interventions are implemented, the patient begins to show subtle signs of stabilization. Over the course of a week, his heart rate and blood pressure gradually return to more acceptable levels, and the PVCs become less frequent. The patient reports a slight decrease in dizziness and palpitations, although the paranoia and auditory hallucinations persist. The healthcare team recognizes that while the immediate physical complications are being managed, ongoing monitoring and adjustments to the treatment regimen are essential to support the patient's long-term recovery and mental health stabilization. This progress paves the way for further therapeutic engagement and refinement of the patient's care plan.

Section 5

As the healthcare team continues to monitor the patient, new complications arise that require immediate attention and clinical reasoning. Over the next several days, the patient experiences an unexpected increase in anxiety and agitation, disrupting the initial progress. The nursing staff conducts a thorough assessment and notes that the patient exhibits increased restlessness, pacing, and verbal outbursts related to his persistent paranoid delusions. Vital signs reveal a slight increase in blood pressure to 150/90 mmHg and a heart rate of 95 beats per minute, suggesting a potential stress response. Interestingly, the patient denies any new physical symptoms such as dizziness or palpitations, which had previously been problematic.

In light of these developments, the healthcare team orders a series of new diagnostic tests, including a repeat EKG and a serum cortisol level assessment, to investigate potential underlying causes of the exacerbated anxiety. The EKG shows no significant changes from previous results, but the cortisol levels return elevated, indicating a possible stress-related endocrine response. The team hypothesizes that the patient's heightened anxiety and agitation may be linked to the fluctuating cortisol levels, exacerbated by the ongoing stress of the psychiatric symptoms.

To address these complications, the treatment plan is adjusted to include the introduction of a low-dose atypical antipsychotic, known for its anxiolytic properties, alongside the existing long-acting injectable antipsychotic. This adjustment aims to target both the psychotic symptoms and the anxiety more effectively. The nursing staff is trained to implement relaxation techniques and mindfulness exercises to help the patient manage his stress levels. The team remains vigilant, recognizing the need for continuous evaluation of the patient's response to these interventions and any further adjustment required to optimize his mental health stabilization.